Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bismarck F Hernández-Álvarez"'
Autor:
Santiago Avila-Ríos, Claudia García-Morales, Margarita Matías-Florentino, Daniela Tapia-Trejo, Bismarck F Hernández-Álvarez, Sumaya E Moreira-López, Carlos J Quant-Durán, Guillermo Porras-Cortés, Gustavo Reyes-Terán
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164156 (2016)
BACKGROUND:Increasing HIV pre-treatment drug resistance (PDR) levels have been observed in regions with increasing antiretroviral treatment (ART) coverage. However, data is lacking for several low/middle-income countries. We present the first PDR sur
Externí odkaz:
https://doaj.org/article/ef16b09bade14d168235467a6c3441e6
Autor:
Gustavo Reyes-Terán, Carlos Quant-Durán, Claudia García-Morales, Guillermo Porras-Cortés, Margarita Matías-Florentino, Bismarck F. Hernández-Álvarez, Daniela Tapia-Trejo, Santiago Ávila-Ríos, Sumaya E. Moreira-López
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164156 (2016)
PLoS ONE
PLoS ONE
Background Increasing HIV pre-treatment drug resistance (PDR) levels have been observed in regions with increasing antiretroviral treatment (ART) coverage. However, data is lacking for several low/middle-income countries. We present the first PDR sur
Autor:
Bismarck F. Hernández-Álvarez, Guillermo Porras-Cortés, Gustavo Reyes-Terán, Carlos Quant-Durán, Sumaya E. Moreira-López, Santiago Ávila-Ríos, Daniela Tapia-Trejo, Claudia García-Morales
Publikováno v:
Open Forum Infectious Diseases. 2
Guillermo Porras-Cortes, MD2*; Santiago Avila-Rios, PhD1; Claudia Garcia-Morales, MSc1; Daniela Tapia-Trejo1; Sumaya Moreira-Lopez, MD2; Bismarck Hernandez-Alvarez3; Carlos Quant-Duran, MD2,3*; Gustavo Reyes-Teran, MD1* 1Centre for Research in Infect